Imidazo[1,2-a]pyrazin-8-ylamines method of making and method of use thereof

Details for Australian Patent Application No. 2003221731 (hide)

Owner CGI Pharmaceuticals, Inc.

Inventors DeSimone, Robert Walter Jr.; Currie, Kevin S.; Pippin, Douglas A.; Mitchell, Scott A.; Darrow, James W.

Agent Davies Collison Cave

Pub. Number AU-B-2003221731

PCT Number PCT/US03/12222

PCT Pub. Number WO2003/089434

Priority 60/374,213 19.04.02 US

Filing date 21 April 2003

Wipo publication date 3 November 2003

Acceptance publication date 15 April 2010

International Classifications

C07D 487/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/282 (2006.01)

A61K 31/337 (2006.01) - having four-membered rings, e.g. taxol

A61K 31/407 (2006.01) - condensed with heterocyclic ring systems, e.g. ketorolac, physostigmine

A61K 31/4985 (2006.01) - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61K 31/704 (2006.01)

A61K 31/7048 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/10 (2006.01) Drugs for disorders of the endocrine system

A61P 5/14 (2006.01) Drugs for disorders of the endocrine system

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/08 (2006.01) Drugs for disorders of the respiratory system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/00 Drugs for skeletal disorders

Event Publications

7 August 2003 Complete Application Filed

  Priority application(s): 60/374,213 19.04.02 US

11 December 2003 Application Open to Public Inspection

  Published as AU-B-2003221731

24 February 2005 Amendment Made

  The nature of the amendment is: Add the name of the co-inventors Currie, Kevin S.; Mitchell, Scott A. 2003226406 3M Innovative Properties Company The nature of the amendment is: Amend the invention title to read Sustained release microcapsules containing semiochemicals

10 September 2009 Alteration of Name

  The name of the applicant has been altered to CGI Pharmaceuticals, Inc.

15 April 2010 Application Accepted

  Published as AU-B-2003221731

12 August 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003221732-Digital audio broadcasting method and apparatus using complementary pattern-mapped convolutional codes

2003221730-METHOD AND SOFTWARE FOR ENABLING N-WAY COLLABORATIVE WORK OVER A NETWORK OF COMPUTERS